CBPO - China Biologic Products Holdings, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/12/2019
30/12/2018
30/12/2017
30/12/2016
Total revenue
503,745
503,745
466,878
370,407
341,169
Cost of revenue
174,667
174,667
146,787
125,517
124,034
Gross profit
329,078
329,078
320,090
244,890
217,135
Operating expenses
Research development
11,735
11,735
9,524
6,504
7,022
Selling general and administrative
153,696
153,696
164,393
102,528
66,198
Total operating expenses
165,430
165,430
173,918
109,031
73,220
Operating income or loss
163,648
163,648
146,173
135,859
143,915
Interest expense
558
558
338
583
254
Total other income/expenses net
7,081
7,081
6,462
3,509
2,443
Income before tax
191,494
191,494
166,003
146,408
153,919
Income tax expense
28,099
28,099
18,036
64,172
25,126
Income from continuing operations
163,395
163,395
147,967
82,236
128,793
Net income
138,808
138,808
128,056
67,943
104,779
Net income available to common shareholders
137,117
137,117
124,984
65,754
101,792
EBITDA
-
218,292
189,567
159,900
166,912